ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 1387 • 2018 ACR/ARHP Annual Meeting

    Fatigue in Patients with Rheumatoid Arthritis As Compared to Different Groups of Cancer Patients

    Jens Gert Kuipers1, Michael Koller2, Ulrich Rueffer3, Florian Zeman2, Karolina Mueller4 and Joachim Weis5, 1Clinic for Internal Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, 2Center of Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 3German Fatigue Society, Cologne, Germany, 4Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, 5University Clinic Centre Freiburg, Freiburg, Germany

    Background/Purpose: Fatigue is a common symptom in patients with rheumatoid arthritis (RA) as well as patients with cancer. Fatigue considerably reduces the quality of life…
  • Abstract Number: 1393 • 2018 ACR/ARHP Annual Meeting

    Fatigue in Men and Women with Psoriatic Arthritis: An International Qualitative Study

    Ana-Maria Orbai1, Suzanne Grieb2, Lilian van Tuyl3, Penelope Palominos4, Ying Ying Leung5, Karen Schipper6, Willemina Campbell7, Jessica Walsh8, Katherine Clegg Smith9, Laure Gossec10, Tania Gudu11, Premarani Sinnathurai12, Lyn March13, Soumya M. Reddy14, Xin Xiao Hui15, Clifton O. Bingham III16, Ricardo M. Xavier17 and Maarten de Wit18, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Johns Hopkins Bayview Medical Center, Center for Child and Community Health Research, Baltimore, MD, 3Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 4Rheumatology, Hospital de Clinicas de Porto Alegre, Santa Cecilia, Brazil, 5North District Hospital, Hong Kong, China, 6VU University, Amsterdam, Netherlands, 7Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, 8University of Utah School of Medicine, Salt Lake City, UT, USA, Salt Lake City, UT, 9Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Batimore, MD, 10Sorbonne Universités, Paris, France, 11University of Medicine Carol Davila Bucuresti, Romania, Bucuresti, Romania, 12Rheumatology, University of Sydney, Sydney, Australia, 13Department of Rheumatology, Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia, 14Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 15Rheumatology, Singapore General Hospital, Singapore, Singapore, 16Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 17Universidade Federal do Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil, 18EULAR standing committee of PARE, Zurich, Switzerland

    Background/Purpose: Fatigue is prevalent and important to people with psoriatic arthritis (PsA)1.  Women with PsA have worse symptom and life impact scores than men, including…
  • Abstract Number: 1402 • 2018 ACR/ARHP Annual Meeting

    The Relationship of Pain, Fatigue and Emotional Distress with Quality of Life in Juvenile Myositis

    Kyle J. Fahey1, Elizabeth L. Gray2, Rowland W. Chang3, David Cella4, Lauren M. Pachman5 and Kaveh Ardalan6, 1Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Preventive Medicine, Medicine, and Physical Medicine & Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Departments of Medical Social Sciences, Neurology, Pediatrics, Preventive Medicine, and Psychiatry and Behavioral Sciences,, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Cure JM Program of Excellence in Juvenile Myositis Research, Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, 6Departments of Pediatrics and Medical Social Sciences, Division of Rheumatology, Northwestern University Feinberg School of Medicine/Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL

    Background/Purpose: Juvenile Myositis (JM) is an autoimmune disease that negatively impacts quality of life (QoL) outcomes via muscle weakness and vasculopathic rashes. The relative contribution…
  • Abstract Number: 1918 • 2018 ACR/ARHP Annual Meeting

    Defining Pain That Does Not Interfere with Activities Among Rheumatoid Arthritis (RA) Patients

    Yvonne C. Lee1, Patricia Katz2,3, Amanda Quebe4, Luna Sun4, Himanshu Patel4, Carol L. Gaich4, Natalie Boytsov4 and Kaleb Michaud5,6, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Forward/National Data Bank for Rheumatic Diseases, Wichita, KS, 3University of California San Francisco, San Francisco, CA, 4Eli Lilly and Company, Indianapolis, IN, 5Rheumatology, University of Nebraska Medical Center, Omaha, NE, 6FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: RA patients differ in the degree to which pain interferes with function. To improve function, an understanding of this diversity is needed. Our objectives…
  • Abstract Number: 2376 • 2018 ACR/ARHP Annual Meeting

    Something for Us: Client Perspectives on Lupus Self-Management Programming Using the 5-a Behavior Change Model

    Brenda L Frie, Occupational Therapy Dept., St. Catherine University, St. Paul, MN

    Background/Purpose: Systemic lupus erythematosus is the most common and most severe form of lupus involving multiple body systems including the blood, muscles, joints, organs and…
  • Abstract Number: 1354 • 2017 ACR/ARHP Annual Meeting

    Fatigue, Poor Health and Mood Disturbance Persist in Rheumatoid Arthritis and Psoriatic Arthritis Patients Despite Disease Remission: The OPAL Deeper Study

    Paul Bird1, Hedley Griffiths2, Geoff Littlejohn3, Peter Youssef4, Fred Joshua5, Peter Nash6, Julien De Jager7, Tegan Smith8, Janet Sanburg9 and Kathleen Tymms10, 1University of New South Wales, Sydney, Australia, 2Barwon Rheumatology Service, Geelong, Australia, 3Medicine, Monash, Melbourne, Australia, 4Royal Prince Alfred Hospital, Camperdown, Sydney, Australia, 5Combined Rheumatology Practice, Sydney, NSW, Australia, 6University of Queensland, Brisbane, Australia, 7University Of Queensland, Southport, Australia, 8OPAL, Sydney, Australia, 9OPAL, Melbourne, Australia, 10ANU, Canberra, Australia

    Background/Purpose: Patient reported outcomes are recognized as increasingly important in defining the full burden of disease experienced by patients with rheumatic disease. Traditional measures of…
  • Abstract Number: 1388 • 2017 ACR/ARHP Annual Meeting

    Fatigue Is Strongly Associated with the Patient Global Assessment and May Affect Disease Severity and Clinical Remission in Patients with Rheumatoid Arthritis: A Cross-Sectional Study from IORRA, a Large Observational Cohort of Japanese Rheumatoid Arthritis Patients

    Naoki Sugimoto1, Eiichi Tanaka1, Eisuke Inoue1,2, Kumiko Saka1, Eri Sugano1, Naohiro Sugitani1, Moeko Ochiai1, Yoko Shimizu1, Rei Yamaguchi1, Katsunori Ikari1, Ayako Nakajima1, Atsuo Taniguchi1 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Division of Medical Informatics, St. Marianna University School of Medicine, Kawasaki, Japan

    Background/Purpose: Fatigue is a common complaint in patients with rheumatoid arthritis (RA)1. However, its impact on disease activity and clinical remission in patients with RA…
  • Abstract Number: 1500 • 2017 ACR/ARHP Annual Meeting

    Longitudinal Analysis of Different Therapeutic Strategies in Patients with Primary Sjögren’s Syndrome

    Kristen Davies1, Kamran Mirza1, Jessica Tarn2, Marian Regan3, Saravanan Vadivelu4, Gavin Clunie5, Jacqueline Andrews6, Elizabeth Price7, Steve Young-Min8, Ian Giles9, Bhaskar Dasgupta10, Cathy Lawson11, Nagui Gendi12, Neil J. McHugh13, Michele Bombardieri14, Costantino Pitzalis14, Nurhan Sutcliffe14, Simon Bowman15, Dennis Lendrem16,17 and Wan-Fai Ng2,18, 1Institute of Cellular Medicine, Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 3Royal Derby Hospital, Derby, UK, Derby, United Kingdom, 4Queen Elizabeth Hospital, Gateshead, UK, Gateshead, United Kingdom, 5Ipswich Hospital NHS Trust, Ipswich, UK, Ipswich, United Kingdom, 6Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds, United Kingdom, 7Great Western Hospital, Swindon, UK, Swindon, United Kingdom, 8Queen Alexander Hospital, Portsmouth, UK, Portsmouth, United Kingdom, 9Centre for Rheumatology, University College London, Centre for Rheumatology, University College London, UK, London, United Kingdom, 10Rheumatology, Southend University Hospital NHS Foundation Trust, Southend, UK, Westcliff-on-Sea, United Kingdom, 11Harrogate District Hospital, Harrogate, UK, Harrogate, United Kingdom, 12Basildon and Thurrock University Hospital, Basildon, UK, Basildon, United Kingdom, 13Royal National Hospital for Rheumatic Diseases, Bath, UK, Bath, United Kingdom, 14Barts Health NHS Trust & Barts and the London School of Medicine & Dentistry, London, UK, London, United Kingdom, 15Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, United Kingdom, 16Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-upon-Tyne, United Kingdom, 17Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle, United Kingdom, 18Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune rheumatic disease characterised by sicca features and systemic manifestations such as pain and fatigue. The classic…
  • Abstract Number: 1528 • 2017 ACR/ARHP Annual Meeting

    Secukinumab Provides Rapid and Sustained Pain Relief in Ankylosing Spondylitis Patients with Normal or Elevated Baseline CRP Levels and Correlated with Improvement in Fatigue

    Atul A. Deodhar1, Philip G. Conaghan2, Tore K Kvien3, Vibeke Strand4, Lawrence Rasouliyan5, Brian Porter6, Steffen Jugl7 and Kunal Gandhi6, 1Oregon Health & Science University, Portland, OR, 2University of Leeds, Leeds, United Kingdom, 3Diakonhjemmet Hospital, Oslo, Norway, 4Stanford University School of Medicine, Palo Alto, CA, 5RTI Health Solutions, Barcelona, Spain, 6Novartis Pharmaceuticals Corporation, East Hanover, NJ, 7Novartis Pharma AG, Basel, Switzerland

    Background/Purpose: Secukinumab has demonstrated sustained efficacy in patients (pts) with active AS.1,2 We investigated improvement in pain and fatigue scores from baseline (BL) through Week…
  • Abstract Number: 1602 • 2017 ACR/ARHP Annual Meeting

    Fatigue in Systemic Lupus: The Role of Disease Activity and Its Mediators

    Desiree R Azizoddin1, Meenakshi Jolly2, Joel A. Block3 and Perry M. Nicassio4, 1Department of Medicine and Behavioral Sciences, Rush University, Chicago, IL, 2Rush, Chicago, IL, 3Division of Rheumatology, Rush University Medical Center, Chicago, IL, 4Cousins Center for PNI, UCLA, LA, CA

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that leads to a variety of negative health outcomes. Though treatment continues to advance, fatigue…
  • Abstract Number: 2254 • 2017 ACR/ARHP Annual Meeting

    Disability (HAQ) and Quality of Life (SF-12) As Related to Adherence and Health Literacyin Patients with Rheumatoid Arthritis – the Trace-Study

    Jens Gert Kuipers1, Michael Koller2, Florian Zeman2, Karolina Mueller2 and Jens Ulrich Rueffer3, 1Department of Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, 2University Hospital Regensburg, Center for Clinical Studies, Regensburg, Germany, 3German Fatigue Society, Cologne, Germany

    Background/Purpose: Disabilities in daily living and quality of life are key endpoints to evaluate the outcome of treatment for rheumatoid arthritis (RA). Among factors that…
  • Abstract Number: 2538 • 2017 ACR/ARHP Annual Meeting

    Change in Self-Reported Health Status and Fatigue before and after the Diagnosis of Psoriatic Arthritis- the Nord-Trondelag Health Study (HUNT)

    Mari Hoff1, Tom Ivar Lund Nilsen2, Ruth Stoklund Thomsen3, Agnete Malm Gulati4, Arthur Kavanaugh5 and Glenn Haugeberg4, 1Rheumatolgy, University Hospital, St. Olavs Hospital, NTNU, Trondheim, Norway, 2Faculty of medicine, Department of public health and nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway, 3Faculty of Medicine, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway, 4NTNU, Norwegian University of Science and Technology, Trondheim, Norway, 5Medicine, University of California, San Diego, La Jolla, CA

    Background/Purpose: Psoriatic arthritis (PsA) is a systemic inflammatory disease that can involve skin, nails, joints, enthuses, and can be associated with systemic symptoms such as…
  • Abstract Number: 2615 • 2017 ACR/ARHP Annual Meeting

    Non-Pharmacological Treatment on Fatigue, Depression, Disease Activity, and Quality of Life of Systemic Lupus Erythematosus: A Systematic Review

    Monthida Fangtham1, Jacob Louis Nash2, Stephanie Hyon3, Raveendhara R. Bannuru4 and Chenchen Wang3, 1Internal Medicine, University of New Mexico, Albuquerque, NM, 2Health Sciences Library and Informatics Center, University of New Mexico, Albuquerque, NM, 3Rheumatology, Center of Integrative Medicine and Division of Rheumatology, Tufts Medical Center, Boston, MA, Boston, MA, 4Center of Integrative Medicine and Division of Rheumatology, Tufts Medical Center, Boston, MA, Boston, MA

    Background/Purpose: In recent years, non-pharmacological therapies have been deemed as potentially beneficial for patients with systemic lupus erythematosus (SLE). These include complementary and integrative approaches,…
  • Abstract Number: 2912 • 2017 ACR/ARHP Annual Meeting

    The Neural Correlates of Inflammation in RA: A Multi-Modal MRI Study

    Andrew Schrepf1, Chelsea Cummiford1, Eric Ichesco1, Tony Larkin1, Steven E. Harte1, Richard E. Harris1, Alison Murray2, Gordon Waiter3, Daniel J. Clauw4 and Neil Basu5, 1Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Aberdeen Brain Imaging Center, University of Aberdeen, Aberdeen, United Kingdom, 3Aberdeen Brain Imaging Centre, University of Aberdeen, Aberdeen, United Kingdom, 4Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI, 5Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom

    Background/Purpose: Inflammation is the hallmark of disease activity in rheumatoid arthritis (RA). RA is characterized by fatigue and cognitive/affective disturbances, and these symptoms often worsen…
  • Abstract Number: 2955 • 2017 ACR/ARHP Annual Meeting

    Does Guideline-Based Care Improve Outcomes That Matter to Patients? Tighter Control, Less Suffering, and Greater Well-Being over the Past Decade in Canadian RA Patients

    Susan J. Bartlett1,2, Orit Schieir3, Marie-France Valois4, Carol A Hitchon5, Janet E. Pope6, Gilles Boire7, Boulos Haraoui8, Edward C. Keystone9, Diane Tin10, Carter Thorne11 and Vivian P. Bykerk12, 1Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 2Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 4McGill University, Montreal, QC, Canada, 5University of Manitoba, Winnipeg, MB, Canada, 6Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, 7Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, 8Institute de Rheumatologie, Montreal, QC, Canada, 9University of Toronto, Toronto, ON, Canada, 10The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 11University of Toronto, Newmarket, ON, Canada, 122-005, Mt Sinai Hospital, Toronto, ON, Canada

    Background/Purpose: Best practice recommendations can increase quality of care and improve clinical outcomes, however the impact of recommendations on outcomes that matter most to patients…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology